Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563,000
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
136,756
-
Shares change
-
-165,197
-
Total reported value, excl. options
-
$55,744
-
Value change
-
-$59,519
-
Number of buys
-
4
-
Number of sells
-
-10
-
Price
-
$0.4092
Significant Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q1 2023
16 filings reported holding BJDX - Bluejay Diagnostics, Inc. - Common Stock as of Q1 2023.
Bluejay Diagnostics, Inc. - Common Stock (BJDX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 136,756 shares
of 563,000 outstanding shares and own 24% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (36,500 shares), GEODE CAPITAL MANAGEMENT, LLC (29,139 shares), VANGUARD GROUP INC (15,899 shares), JANE STREET GROUP, LLC (12,254 shares), NORTHERN TRUST CORP (11,699 shares), CITADEL ADVISORS LLC (10,462 shares), Tower Research Capital LLC (TRC) (10,202 shares), Virtu Financial LLC (10,031 shares), ADVISOR GROUP HOLDINGS, INC. (500 shares), and WELLS FARGO & COMPANY/MN (70 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.